Business
Australian Clinical Labs terms: $408.6m IPO at $4 a share – The Australian Financial Review
Stockbrokers Bank of America and Goldman Sachs have widened the buyer search for IPO hopeful Australian Clinical Labs.
Stockbrokers Bank of America and Goldman Sachs have widened the buyer search for IPO hopeful Australian Clinical Labs.
The brokers equities desks sent terms to fund managers on Wednesday morning, and said they would be back with an institutional bookbuild to sell shares and lock in the listing on Tuesday April 27.
Street Talk. Erin Jonasson
The term sheet said Australian Clinical Labs would seek to raise $408.6 million at $4 a share.
The price represented 15-times forecast profit for the 2021 calendar…
-
Noosa News23 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News22 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
Business9 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General18 hours ago‘Potential’ hacker contacts Qantas over data breach